Covaxin beneficiaries to be followed up for 3 months after receiving 2nd dose

The ICMR has issued the key Standard Operating Procedure (SoP) for use of Covaxin under clinical trial mode. The Sop’s stated that “He/she will return to the session site on day 28 or on the date given to him/her for the 2nd dose of Covaxin. All the vaccine recipients will be followed-up for a period of 3 months after the second dose of vaccination.”

The individual that have any allergic history, fever, have an impaired immune system, are on a blood thinner, pregnant, breastfeeding, have received other COVID-19 Vaccine, or any serious health issues according to the Vaccinator, will not be eligible for vaccination. If the recipient suffers through any serious condition any time after vaccination, he/she must inform the vaccinator and report for treatment to a nearest healthcare facility.

India has given emergency use authorisation to Covaxin and Covidshield.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy